Columbia Wanger Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-246,107
Closed -$11.6M 215
2017
Q3
$11.6M Sell
246,107
-19,989
-8% -$805K 0.17% 166
2017
Q2
$9.41M Sell
266,096
-87,703
-25% -$2.71M 0.13% 180
2017
Q1
$8.36M Sell
353,799
-510,334
-59% -$10.1M 0.12% 185
2016
Q4
$11.5M Buy
864,133
+305,699
+55% +$4.94M 0.16% 167
2016
Q3
$10.4M Sell
558,434
-211,566
-27% -$3.73M 0.14% 180
2016
Q2
$9.43M Buy
+770,000
New +$5.8M 0.11% 187

Other funds holding EXAS

Columbia Wanger Asset Management's EXAS Position: Q4 2017 in Review

Columbia Wanger Asset Management sold out of Exact Sciences (EXAS) in Q4 2017, closing a stake of 246,107 shares — an estimated $11.6M sold.

Columbia Wanger Asset Management first reported a position in EXAS in Q2 2016 and held it in 6 quarters. The position peaked at $11.6M in Q3 2017. 318 funds tracked by Wall St. Rank hold EXAS as of Q4 2017.

  • Columbia Wanger Asset Management reported no remaining Exact Sciences position as of Q4 2017 after selling out during the quarter.
  • Columbia Wanger Asset Management sold 246,107 Exact Sciences shares in Q4 2017, an estimated $11.6M.
  • Columbia Wanger Asset Management first reported a position in Exact Sciences in Q2 2016 and held it in 6 quarters.
  • Columbia Wanger Asset Management's Exact Sciences position peaked at $11.6M in Q3 2017.
  • 318 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.